Literature DB >> 8142621

Acute promyelocytic leukaemia and the t(15;17) translocation.

E F Gillard1, E Solomon.   

Abstract

Acute promyelocytic leukaemia (APL) is a rare acute myeloid leukaemia characterized by a distinctive coagulopathy, the differentiation of promyelocytes in response to all-trans retinoic acid and a reciprocal chromosomal translocation, t(15;17)(q22;q12-q21). Molecular analysis of the APL breakpoint has revealed the involvement of the retinoic acid receptor alpha (RARA) gene on chromosome 17 and the promyelocytic leukaemia (PML) gene on chromosome 15. Both reciprocal fusion products which arise as a result of the translocation, PML/RAR alpha and RAR alpha/PML, are expressed in many patients. PML/RAR alpha, is implicated in leukaemogenesis, and may block myeloid differentiation directly and/or interfere with the normal function(s) of PML and/or RAR alpha.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8142621

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  4 in total

Review 1.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 2.  The role of the immune system in anti-tumour responses. Potential for drug therapy.

Authors:  S Dermime; J Barrett; C Gambacorti-Passerini
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

3.  Retinoic acid receptor alpha suppresses transformation by v-myb.

Authors:  J Smarda; J Sugarman; C Glass; J Lipsick
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 4.  The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models.

Authors:  James Neil Fisher; Natarajaswamy Kalleda; Vaia Stavropoulou; Juerg Schwaller
Journal:  Hemasphere       Date:  2019-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.